1. Home
  2. SNGX vs PLAG Comparison

SNGX vs PLAG Comparison

Compare SNGX & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Soligenix Inc.

SNGX

Soligenix Inc.

N/A

Current Price

$0.37

Market Cap

8.2M

Sector

Health Care

ML Signal

N/A

PLAG

Planet Green Holdings Corp.

N/A

Current Price

$0.70

Market Cap

8.6M

ML Signal

N/A

Company Overview

Basic Information
Metric
SNGX
PLAG
Founded
1987
1986
Country
United States
United States
Employees
N/A
6
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
8.2M
8.6M
IPO Year
2006
2007

Fundamental Metrics

Financial Performance
Metric
SNGX
PLAG
Price
$0.37
$0.70
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
200.0K
★ 636.8K
Earning Date
11-06-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 57.03
32.56
EPS
N/A
★ N/A
Revenue
$119,371.00
★ $3,040,616.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.28
$0.49
52 Week High
$1.97
$6.81

Technical Indicators

Market Signals
Indicator
SNGX
PLAG
Relative Strength Index (RSI) 40.65 47.16
Support Level $0.35 $0.65
Resistance Level $0.41 $0.77
Average True Range (ATR) 0.01 0.04
MACD -0.00 0.01
Stochastic Oscillator 14.44 39.13

Price Performance

Historical Comparison
SNGX
PLAG

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

About PLAG Planet Green Holdings Corp.

Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.

Share on Social Networks: